Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL246985 | 0.81 | USP2 (0.55) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL1062215 | 0.81 | PDE4A (0.52) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL1704734 | 0.81 | PDE4A (0.52) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL27438858 | 0.81 | PDE4A (0.52) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL133815 | 0.80 | USP2 (0.53) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL8658675 | 0.79 | PDE4A (0.50) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL1843798 | 0.79 | PDE4A (0.43) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL18825591 | 0.79 | PDE4A (0.43) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL858818 | 0.79 | PDE4A (0.43) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL28292381 | 0.79 | PDE4A (0.43) | USP2SLCO1B1LMNAL3MBTL1PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111620916-A | Synthesis method of alkyl amino glucoside | 天津科技大学 | 2020-09-04 | — | — | CN | claimed |
| CN-108425145-A | A kind of nontoxic copper and iron base silver decoating liquid and its withdrawal plating | 泉州市蓝水环保科技有限公司 | 2018-08-21 | — | — | CN | claimed |
| CN-118338891-A | Cosmetic composition comprising a rheology-modified and stabilized polymer blend | 莱雅公司 | 2024-07-12 | — | — | CN | disclosed |
| US-12016919-B2 | Methods for manufacturing an adjuvant | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-06-25 | — | — | US | disclosed |
| CN-118176286-A | Membrane and capsule | 联合利华知识产权控股有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-118103023-A | Retarder composition and dye set comprising same | 莱雅公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2024084091-A1 | MATERIALS AND METHODS TO TREAT EPSTEIN-BARR VIRUS (EBV) AND EBV-INDUCED DISEASES | MEDIZINISCHE UNIVERSITÄT WIEN (AT) | 2024-04-25 | — | — | WO | disclosed |
| CN-117916353-A | Membrane and capsule | 联合利华知识产权控股有限公司 | 2024-04-19 | — | — | CN | disclosed |
| US-20240115688-A1 | Novel Antigens | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-04-11 | — | — | US | disclosed |
| US-20240076318-A1 | EPSTEIN-BARR VIRUS ANTIGEN CONSTRUCTS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-03-07 | — | — | US | disclosed |
| CN-110179974-B | Vaccine | 葛兰素史密丝克莱恩生物有限公司 | 2024-01-09 | — | — | CN | disclosed |
| WO-2005065714-A1 | INTRANASAL ADMINISTRATION OF GLUCOSE-REGULATING PEPTIDES | NASTECH PHARMACEUTICAL COMPANY INC. (US) | 2005-07-21 | — | — | WO | disclosed |
| US-20050143303-A1 | Intranasal administration of glucose-regulating peptides | NASTECH PHARMACEUTICAL COMPANY INC. | 2005-06-30 | — | — | US | disclosed |
| EP-1505971-A2 | ADMINISTRATION OF ACETYLCHOLINESTERASE INHIBITORS TO THE CEREBRAL SPINAL FLUID | Nastech Pharmaceutical Company Inc. (US) | 2005-02-16 | — | — | EP | disclosed |
| WO-2004002402-A2 | ADMINISTRATION OF ACETYLCHOLINESTERASE INHIBITORS TO THE CEREBRAL SPINAL FLUID | NASTECH PHARMACEUTICAL COMPANY INC. (US) | 2004-01-08 | — | — | WO | disclosed |
| US-20030225031-A1 | Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid | NASTECH PHARMACEUTICAL COMPANY INC. | 2003-12-04 | — | — | US | disclosed |
| EP-0769499-B1 | 1-(2,3-Dihydroxypropyl)-2-deoxy-2-(alkyloxyamino)glucopyranoside their preparation and their uses | CECA SA (FR) | 2001-01-10 | — | — | EP | disclosed |
| EP-0769499-A1 | 1-(2,3-Dihydroxypropyl)-2-deoxy-2-(alkyloxyamino)glucopyranoside their preparation and their uses | CECA S.A. (FR) | 1997-04-23 | — | — | EP | disclosed |
| US-4250301-A | Anomer enrichment of alkyl glycosides of amino sugars | UNIVERSITY OF DELAWARE (US) | 1981-02-10 | — | — | US | disclosed |
| US-4152513-A | CONTINUOUSLY AZEOTROPING BYPRODUCT WATER INFLUENCES RATIO OF ISOMERS | UNIVERSITY OF DELAWARE (US) | 1979-05-01 | — | — | US | disclosed |